Akebia Therapeutics | AKBA - Debt


Akebia Therapeutics reported $46.51M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Acadia Pharmaceuticals USD 52.19M 2.62M Dec/2025
Agios Pharmaceuticals USD 35.74M 4.46M Mar/2026
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alnylam Pharmaceuticals USD 1.27B 5.33M Mar/2026
Amgen USD 54.6B 17M Dec/2025
Ardelyx USD 208.26M 653K Mar/2026
Astellas Pharma JPY 831.43B 83.94B Mar/2025
AstraZeneca USD 32.24B 1.68B Jun/2026
Bayer EUR 36.45B 2.93B Dec/2025
BioMarin Pharmaceutical USD 1.44B 833.74M Mar/2026
Celltrion KRW 160.58B 733.3M Mar/2026
Cspc Pharmaceutical CNY 641.11M 146.11M Dec/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Exelixis USD 169.54M 3.5M Mar/2026
Fresenius Medical Care EUR 11.03B 233.8M Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 54.99B 7.05B Mar/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Lexicon Pharmaceuticals USD 99.51M 243K Dec/2023
Moderna USD 1.3B 7M Mar/2026
Nektar Therapeutics USD 0 0 Jun/2022
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 8.2M 554K Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 45.84M 1.7M Jun/2026
Prothena USD 7.65M 1.43M Mar/2026
PTC Therapeutics USD 286.94M 2.42B Mar/2026
Qiagen NV USD 1.65B 165.82M Mar/2026
Regeneron Pharmaceuticals USD 2.71B 400K Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
Sarepta Therapeutics USD 1.04B 210.44M Dec/2025
Sartorius EUR 4.05B 248.8M Jun/2026
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 640.95M 35.17M Jun/2022
Vanda Pharmaceuticals USD 4.96M 4.96M Dec/2024
Zealand Pharma A/S 414M 8.23M Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026